Background: Asthma and especially severe asthma affect women more frequently than men. Since asthma severity correlates with remodeling changes in the lung, a female propensity to remodeling could be expected. We studied whether our previous observation that female mice have more pronounced airway inflammation than males is associated with more pronounced remodeling in two models of chronic allergic asthma. Methods: Male and female BALB/c mice were (1) sensitized and subsequently challenged with ovalbumin (OVA) for 4 weeks, or (2) exposed to house dust mite (HDM) for 5 weeks. In both models, allergic inflammation, remodeling, antigen-specific IgE and methacholine (MCh) responsiveness were assessed. Results: Females had higher antigen-specific serum IgE levels, higher numbers of eosinophils and were more responsive to MCh. In the OVA model, females also had higher levels of Th2 cytokines in lung tissue than males. Both sexes developed similar airway remodeling (smooth muscle layer thickness, collagen III deposition and goblet cell hyperplasia) in the two models. Conclusions: Combining results of an OVA- and a HDM-induced mouse model of allergic airway inflammation, we have shown that more severe allergic inflammation in females is not accompanied with more pronounced airway remodeling.

Keywords:
Airway responsiveness, Allergic airway inflammation, Eosinophilic inflammation, House dust mite, IL-4, IL-17, IgE, Ovalbumin, Remodeling, Sex
1.
Pepe C, Foley S, Shannon J, Lemiere C, Olivenstein R, Ernst P, Ludwig MS, Martin JG, Hamid Q: Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol 2005;116:544–549.
2.
Holgate ST, Holloway J, Wilson S, Bucchieri F, Puddicombe S, Davies DE: Epithelial-mesenchymal communication in the pathogenesis of chronic asthma. Proc Am Thorac Soc 2004;1:93–98.
3.
Saglani S, Payne DN, Zhu J, Wang Z, Nicholson AG, Bush A, Jeffery PK: Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med 2007;176:858–864.
4.
Barbato A, Turato G, Baraldo S, Bazzan E, Calabrese F, Panizzolo C, Zanin ME, Zuin R, Maestrelli P, Fabbri LM, Saetta M: Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med 2006;174:975–981.
5.
Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP, Sears MR: Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med.
6.
Cokugras H, Akcakaya N, Seckin, Camcioglu Y, Sarimurat N, Aksoy F: Ultrastructural examination of bronchial biopsy specimens from children with moderate asthma. Thorax 2001;56:25–29.
7.
Almqvist C, Worm M, Leynaert B: Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy 2008;63:47–57.
8.
Melgert BN, Postma DS, Kuipers I, Geerlings M, Luinge MA, van der Strate BW, Kerstjens HA, Timens W, Hylkema MN: Female mice are more susceptible to the development of allergic airway inflammation than male mice. Clin Exp Allergy 2005;35:1496–1503.
9.
Corteling R, Trifilieff A: Gender comparison in a murine model of allergen-driven airway inflammation and the response to budesonide treatment. BMC Pharmacology 2004;4:4.
10.
Melgert BN, Oriss TB, Qi Z, Dixon-McCarthy B, Geerlings M, Hylkema MN, Ray A: Macrophages: regulators of sex differences in asthma? Am J Respir Cell Moll Biol 2009, Jul 2. Epub ahead of print.
11.
Melgert BN, Postma DS, Geerlings M, Luinge MA, Klok PA, van der Strate BW, Kerstjens HA, Timens W, Hylkema MN: Short-term smoke exposure attenuates ovalbumin-induced airway inflammation in allergic mice. Am J Respir Cell Moll Biol 2004;30:880–885.
12.
Blacquiere MJ, Timens W, Melgert BN, Geerlings M, Postma DS, Hylkema MN: Maternal smoking during pregnancy induces airway remodelling in mice offspring. Eur Respir J 2009;33:1133–1140.
13.
Seymour BW, Friebertshauser KE, Peake JL, Pinkerton KE, Coffman RL, Gershwin LJ: Gender differences in the allergic response of mice neonatally exposed to environmental tobacco smoke. Dev Immunol 2002;9:47–54.
14.
Hayashi T, Adachi Y, Hasegawa K, Morimoto M: Less sensitivity for late airway inflammation in males than females in BALB/c mice. Scand J Immunol 2003;57:562–567.
15.
Perkins C, Wills-Karp M, Finkelman FD: IL-4 induces IL-13-independent allergic airway inflammation. J Allergy Clin Immunol 2006;118:410–419.
16.
Park KS, Korfhagen TR, Bruno MD, Kitzmiller JA, Wan H, SE Wert, Khurana Hershey GK, Chen G, Whitsett JA: SPDEF regulates goblet cell hyperplasia in the airway epithelium. J Clin Invest 2007;117:978–988.
17.
Bosse Y, Thompson C, Audette K, Stankova J, Rola-Pleszczynski M: Interleukin-4 and interleukin-13 enhance human bronchial smooth muscle cell proliferation. Int Arch Allergy Immunol 2008;146:138–148.
18.
Payne DNR, Rogers AV, Adelroth E, Bandi V, Guntupalli KK, Bush A, Jeffery PK: Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003;167:78–82.
19.
Koerner-Rettberg C, Doths S, Stroet A, Schwarze J: Reduced lung function in a chronic asthma model is associated with prolonged inflammation, but independent of peribronchial fibrosis. PLoS One 2008;3:e1575.
20.
Ward C, Pais M, Bish R, Reid D, Feltis B, Johns D, Walters EH: Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002;57:309–316.
21.
Lee SY, Kim SJ, Kwon SS, Kim YK, Moon HS, Song JS, Park SH: Relation of airway reactivity and sensitivity with bronchial pathology in asthma. J Asthma 2002;39:537–544.
22.
Woodruff PG, Dolganov GM, Ferrando RE, Donnelly S, Hays SR, Solberg OD, Carter R, Wong HH, Cadbury PS, Fahy JV: Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med 2004;169:1001–1006.
23.
Berend N, Salome CM, King GG: Mechanisms of airway hyperresponsiveness in asthma. Respirology 2008;13:624–631.
24.
James AL, Wenzel S: Clinical relevance of airway remodelling in airway diseases. Eur Respir J 2007;30:134–155.
25.
Card JW, Carey MA, Bradbury JA, DeGraff LM, Morgan DL, Moorman MP, Flake GP, Zeldin DC: Gender differences in murine airway responsiveness and lipopolysaccharide-induced inflammation. J Immunol 2006;177:621–630.
26.
Matsubara S, Swasey CH, Loader JE, Dakhama A, Joetham A, Ohnishi H, Balhorn A, Miyahara N, Takeda K, Gelfand EW: Estrogen determines gender differences in airway responsiveness after allergen exposure. Am J Respir Cell Moll Biol 2008;38:501–508.
27.
Careau E, Proulx LI, Pouliot P, Spahr A, Turmel V, Bissonnette EY: Antigen sensitization modulates alveolar macrophage functions in an asthma model. Am J Physiol Lung Cell Mol Physiol 2006;290:L871–L879.
28.
Letterio JJ, Roberts AB: Regulation of immune responses by TGF-β. Annu Rev Immunol 1998;16:137–161.
29.
Fattouh R, Midence NG, Arias K, Johnson JR, Walker TD, Goncharova S, Souza KP, Gregory RC, Lonning S, Gauldie J, Jordana M: Transforming growth factor-β regulates house dust mite-induced allergic airway inflammation but not airway remodeling. Am J Respir Crit Care Med 2008;177:593–603.
30.
Alcorn JF, Rinaldi LM, Jaffe EF, van Loon M, Bates JH, Janssen-Heininger YM, Irvin CG: Transforming growth factor-β1 suppresses airway hyperresponsiveness in allergic airway disease. Am J Respir Crit Care Med 2007;176:974–982.
31.
Barczyk A, Pierzchala W, Sozanska E: Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 2003;97:726–733.
32.
Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, Olivenstein R, Elias J, Chakir J: IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001;108:430–438.
33.
Schnyder-Candrian S, Togbe D, Couillin I, Mercier I, Brombacher F, Quesniaux V, Fossiez F, Ryffel B, Schnyder B: Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 2006;203:2715–2725.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.